微小肺癌（≤2cm）微創診治探討_Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Authors：

 劉倫旭 , 劉成武

四川大學華西醫院胸外科，成都 610041;

Corresponding?author：

劉倫旭, Email: lunxu_liu@aliyun.com

Keywords：

微小肺癌; 微創; 診斷與治療

DOI：

10.7507/1007-4848.20140166

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 劉倫旭, 劉成武. 微小肺癌（≤2cm）微創診治探討. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2014, 21(5): 577-581. doi: 10.7507/1007-4848.20140166 Copy

1.	Aberle DR, Adams AM, Berg CD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med, 2011, 365(5):395-409.
2.	Travis WD, Brambilla E, Noguchi M, et al. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol, 2011, 6(2):244-285.
3.	Godoy MC, Sabloff B, Naidich DP. Subsolid pulmonary nodules: imaging evaluation and strategic management. Curr Opin Pulm Med, 2012, 18(4):304-312.
4.	Suzuki K, Koike T, Asakawa T, et al. A Prospective radiological study of thin-section computed tomography to predict pathological noninvasiveness in peripheral clinical 1a lung cancer(Japan Clinical Oncology Group 0201). J Thorac Oncol, 2011, 6(4):751-756.
5.	Tsutani Y, Miyata Y, Nakayama H, et al. Solid tumor size on high-resolution computed tomography and maximum standardized uptake on positron emission tomography for new clinical T descriptors with T1 lung adenocarcinoma. Ann Oncol, 2013, 24(9):2376-2381.
6.	Tsutani Y, Miyata Y, Nakayama H, et al. Segmentectomy for clinical stage ⅠA lung adenocarcinoma showing solid dominance on radiology. Euro J Cardio-Thorac Surg, 2014[Epub ahead of print].
7.	Kadota K, Villena-Vargas J, Yoshizawa A, et al. Prognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage Ⅰ disease. Am J Surg Pathol, 2014, 38(4):448-460.
8.	Russell PA, Wainer Z, Wright GM, et al. Does lung adenocarcinoma subtype predict patient survival?:A Clinicopathologic Study Based on the New International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Lung Adenocarcinoma Classification. J Thorac Oncol, 2011, 6(9):1496-1504.
9.	Yoshizawa A, Motoi N, Riely GJ, et al. Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma:prognostic subgroups and implications for further revision of staging based on analysis of 514 stage Ⅰ cases. Mod Pathol, 2011, 24(5):653-664.
10.	Takahashi M, Shigematsu Y, Ohta M, et al. Tumor invasiveness as defined by the newly proposed IASLC/ATS/ERS classification has prognostic significance for pathologic stage ⅠA lung adenocarcinoma and can be predicted by radiologic parameters. J Thorac Cardiovasc Surg, 2014, 147(1):54-59.
11.	Gould MK, Donington J, Lynch WR, et al. Evaluation of individuals with pulmonary nodules:when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed:American College of Chest Physicians evidence-based clinical practice guidelines. Chest, 2013, 143(5 Suppl):e93S-120S.
12.	Wang Memoli JS, Nietert PJ, Silvestri GA. Meta-analysis of guided bronchoscopy for the evaluation of the pulmonary nodule. Chest, 2012, 142(2):385-393.
13.	Lin Y, Liu L, Pu Q. Mini-invasive diagnosis and synchronous treatment of solitary pulmonary nodule. Asian Cardiovasc Thorac Ann, 2013, 21(3):306-312.
14.	Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg, 1995, 60(3):615-622.
15.	Tarasevych S, Lauwers P, Vandaele F, et al. Novel treatment options in stage Ⅰ non-small-cell lung cancer. Expert Rev Anticancer Ther, 2014, 14(9):1-14.
16.	Howington JA, Blum MG, Chang AC, et al. Treatment of stage Ⅰ and Ⅱ non-small cell lung cancer:Diagnosis and management of lung cancer, 3rd ed:American College of Chest Physicians evidence-based clinical practice guidelines. Chest, 2013, 143(5 Suppl):e278S-313S.
17.	Tsutani Y, Miyata Y, Nakayama H, et al. Appropriate sublobar resection choice for ground glass opacity-dominant clinical stage ⅠA lung adenocarcinoma:Wedge resection or segmentectomy. Chest, 2014, 145(1):66-71.
18.	Allen MS, Darling GE, Pechet TT, et al. Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer:initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg, 2006, 81(3):1013-1020.
19.	Maniwa T, Okumura T, Isaka M, et al. Recurrence of mediastinal node cancer after lobe-specific systematic nodal dissection for non-small-cell lung cancer. Eur J Cardiothorac Surg, 2013, 44(1):e59-64.
20.	Shapiro M, Kadakia S, Lim J, et al. Lobe-specific mediastinal nodal dissection is sufficient during lobectomy by video-assisted thoracic surgery or thoracotomy for early-stage lung cancer. Chest, 2013, 144(5):1615-1621.
21.	Yang C-FJ, D'Amico TA. Open, thoracoscopic and robotic segmentectomy for lung cancer. Ann Cardiothorac Surg, 2014, 3(2):142-152.
22.	Liu CY, Lin CS, Shih CH, et al. Single-port video-assisted thoracoscopic surgery for lung cancer. J Thorac Dis, 2014, 6(1):14-21.
23.	Das-Neves-Pereira JC, Bagan P, Coimbra-Israel AP, et al. Fast-track rehabilitation for lung cancer lobectomy:a five-year experience. Eur J Cardiothorac Surg, 2009, 36(2):383-391.
24.	Boujelbene N, Elloumi F, Kamel ME, et al. Stereotactic body radiation therapy in stage Ⅰ inoperable lung cancer:from palliative to curative options. Swiss Med Wkly, 2013, 143:w13780.
25.	Crabtree TD, Denlinger CE, Meyers BF, et al. Stereotactic body radiation therapy versus surgical resection for stage Ⅰ non-small cell lung cancer. J Thorac Cardiovasc Surg, 2010, 140(2):377-386.
26.	Solda F, Lodge M, Ashley S, et al. Stereotactic radiotherapy(SABR)for the treatment of primary non-small cell lung cancer; systematic review and comparison with a surgical cohort. Radiother Oncol, 2013, 109(1):1-7.
27.	Casal RF, Tam AL, Eapen GA. Radiofrequency ablation of lung tumors. Clin Chest Med, 2010, 31(1):151-163.
28.	Lanuti M, Sharma A, Digumarthy SR, et al. Radiofrequency ablation for treatment of medically inoperable stage Ⅰ non-small cell lung cancer. J Thorac Cardiovasc Surg, 2009, 137(1):160-166.
29.	Bi N, Shedden K, Zheng X, et al. Comparison of the Effectiveness of Radiofrequency Ablation With Stereotactic Body Radiation Therapy in Inoperable Stage Ⅰ Non-Small Cell Lung Cancer:A Systemic Review and Meta-analysis. Pract Radiat Oncol, 2013, 3(2 Suppl 1):S19.

1. Aberle DR, Adams AM, Berg CD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med, 2011, 365(5):395-409.
2. Travis WD, Brambilla E, Noguchi M, et al. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol, 2011, 6(2):244-285.
3. Godoy MC, Sabloff B, Naidich DP. Subsolid pulmonary nodules: imaging evaluation and strategic management. Curr Opin Pulm Med, 2012, 18(4):304-312.
4. Suzuki K, Koike T, Asakawa T, et al. A Prospective radiological study of thin-section computed tomography to predict pathological noninvasiveness in peripheral clinical 1a lung cancer(Japan Clinical Oncology Group 0201). J Thorac Oncol, 2011, 6(4):751-756.
5. Tsutani Y, Miyata Y, Nakayama H, et al. Solid tumor size on high-resolution computed tomography and maximum standardized uptake on positron emission tomography for new clinical T descriptors with T1 lung adenocarcinoma. Ann Oncol, 2013, 24(9):2376-2381.
6. Tsutani Y, Miyata Y, Nakayama H, et al. Segmentectomy for clinical stage ⅠA lung adenocarcinoma showing solid dominance on radiology. Euro J Cardio-Thorac Surg, 2014[Epub ahead of print].
7. Kadota K, Villena-Vargas J, Yoshizawa A, et al. Prognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage Ⅰ disease. Am J Surg Pathol, 2014, 38(4):448-460.
8. Russell PA, Wainer Z, Wright GM, et al. Does lung adenocarcinoma subtype predict patient survival?:A Clinicopathologic Study Based on the New International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Lung Adenocarcinoma Classification. J Thorac Oncol, 2011, 6(9):1496-1504.
9. Yoshizawa A, Motoi N, Riely GJ, et al. Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma:prognostic subgroups and implications for further revision of staging based on analysis of 514 stage Ⅰ cases. Mod Pathol, 2011, 24(5):653-664.
10. Takahashi M, Shigematsu Y, Ohta M, et al. Tumor invasiveness as defined by the newly proposed IASLC/ATS/ERS classification has prognostic significance for pathologic stage ⅠA lung adenocarcinoma and can be predicted by radiologic parameters. J Thorac Cardiovasc Surg, 2014, 147(1):54-59.
11. Gould MK, Donington J, Lynch WR, et al. Evaluation of individuals with pulmonary nodules:when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed:American College of Chest Physicians evidence-based clinical practice guidelines. Chest, 2013, 143(5 Suppl):e93S-120S.
12. Wang Memoli JS, Nietert PJ, Silvestri GA. Meta-analysis of guided bronchoscopy for the evaluation of the pulmonary nodule. Chest, 2012, 142(2):385-393.
13. Lin Y, Liu L, Pu Q. Mini-invasive diagnosis and synchronous treatment of solitary pulmonary nodule. Asian Cardiovasc Thorac Ann, 2013, 21(3):306-312.
14. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg, 1995, 60(3):615-622.
15. Tarasevych S, Lauwers P, Vandaele F, et al. Novel treatment options in stage Ⅰ non-small-cell lung cancer. Expert Rev Anticancer Ther, 2014, 14(9):1-14.
16. Howington JA, Blum MG, Chang AC, et al. Treatment of stage Ⅰ and Ⅱ non-small cell lung cancer:Diagnosis and management of lung cancer, 3rd ed:American College of Chest Physicians evidence-based clinical practice guidelines. Chest, 2013, 143(5 Suppl):e278S-313S.
17. Tsutani Y, Miyata Y, Nakayama H, et al. Appropriate sublobar resection choice for ground glass opacity-dominant clinical stage ⅠA lung adenocarcinoma:Wedge resection or segmentectomy. Chest, 2014, 145(1):66-71.
18. Allen MS, Darling GE, Pechet TT, et al. Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer:initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg, 2006, 81(3):1013-1020.
19. Maniwa T, Okumura T, Isaka M, et al. Recurrence of mediastinal node cancer after lobe-specific systematic nodal dissection for non-small-cell lung cancer. Eur J Cardiothorac Surg, 2013, 44(1):e59-64.
20. Shapiro M, Kadakia S, Lim J, et al. Lobe-specific mediastinal nodal dissection is sufficient during lobectomy by video-assisted thoracic surgery or thoracotomy for early-stage lung cancer. Chest, 2013, 144(5):1615-1621.
21. Yang C-FJ, D'Amico TA. Open, thoracoscopic and robotic segmentectomy for lung cancer. Ann Cardiothorac Surg, 2014, 3(2):142-152.
22. Liu CY, Lin CS, Shih CH, et al. Single-port video-assisted thoracoscopic surgery for lung cancer. J Thorac Dis, 2014, 6(1):14-21.
23. Das-Neves-Pereira JC, Bagan P, Coimbra-Israel AP, et al. Fast-track rehabilitation for lung cancer lobectomy:a five-year experience. Eur J Cardiothorac Surg, 2009, 36(2):383-391.
24. Boujelbene N, Elloumi F, Kamel ME, et al. Stereotactic body radiation therapy in stage Ⅰ inoperable lung cancer:from palliative to curative options. Swiss Med Wkly, 2013, 143:w13780.
25. Crabtree TD, Denlinger CE, Meyers BF, et al. Stereotactic body radiation therapy versus surgical resection for stage Ⅰ non-small cell lung cancer. J Thorac Cardiovasc Surg, 2010, 140(2):377-386.
26. Solda F, Lodge M, Ashley S, et al. Stereotactic radiotherapy(SABR)for the treatment of primary non-small cell lung cancer; systematic review and comparison with a surgical cohort. Radiother Oncol, 2013, 109(1):1-7.
27. Casal RF, Tam AL, Eapen GA. Radiofrequency ablation of lung tumors. Clin Chest Med, 2010, 31(1):151-163.
28. Lanuti M, Sharma A, Digumarthy SR, et al. Radiofrequency ablation for treatment of medically inoperable stage Ⅰ non-small cell lung cancer. J Thorac Cardiovasc Surg, 2009, 137(1):160-166.
29. Bi N, Shedden K, Zheng X, et al. Comparison of the Effectiveness of Radiofrequency Ablation With Stereotactic Body Radiation Therapy in Inoperable Stage Ⅰ Non-Small Cell Lung Cancer:A Systemic Review and Meta-analysis. Pract Radiat Oncol, 2013, 3(2 Suppl 1):S19.

Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

微小肺癌（≤2cm）微創診治探討

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content